{"database": "openregs", "table": "documents", "rows": [["FDA-1978-N-0018-0826", "FDA", "FDA-1978-N-0018", "Letter from King & Spalding on behalf of Givaudan-Roure Corporation to FDA/CDER", "Other", "Letter(s)", "2018-04-05T04:00:00Z", 2018, 4, "2018-04-05T04:00:00Z", null, "2019-07-23T16:56:06Z", null, 0, 0, "090000648055a05c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1978-N-0018-0826"], "units": {}, "query_ms": 50.23917800281197, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}